PR-893

CAS No. 1426305-23-8

PR-893( PR 893 | PR893 | CPSI )

Catalog No. M11800 CAS No. 1426305-23-8

A potent, specific immunoproteasome β5 subunit inhibitor with IC50 of 17 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PR-893
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, specific immunoproteasome β5 subunit inhibitor with IC50 of 17 nM.
  • Description
    A potent, specific immunoproteasome β5 subunit inhibitor with IC50 of 17 nM, 21-fold and 13-fold selectivity for β5 over LMP7 and LMP2 subunits, respecitvely.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PR 893 | PR893 | CPSI
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Proteasome
  • Recptor
    Proteasome
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1426305-23-8
  • Formula Weight
    478.546
  • Molecular Formula
    C23H34N4O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    N-((S)-1-(((S)-1-cyclopropyl-2-(((S)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-3-methoxy-1-oxopropan-2-yl)-5-methylisoxazole-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Parlati F, et al. Blood. 2009 Oct 15;114(16):3439-47. 2. de Bruin G, et al. J Med Chem. 2014 Jul 24;57(14):6197-209.
molnova catalog
related products
  • KDM5-inhibitor

    KDM5 inhibitor.

  • (1S,2S)-Bortezomib

    (1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.

  • Delanzomib

    A potent, orally active proteasome inhibitor with IC50 of 3.8 nM against chymotrypsin-like proteasome activity.